HBIO · Harvard Bioscience Inc
Price & Indicators
Raw chart and full-history price indicators begin at the captured split on Mar 16, 2026; bars on opposite sides are not compared.
The closing range begins at the captured split on Mar 16, 2026.
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $2.4M | Six Months Ended June 30, 2026 | — |
|
|
|||
| Adjusted gross margin non-GAAP | 58.3% | Six Months Ended June 30, 2026 | — |
| Adjusted EBITDA margin non-GAAP | 3.7% | Three Months Ended March 31, 2026 | — |
| Adjusted operating income non-GAAP | 231K | Three Months Ended March 31, 2026 | — |
| Adjusted operating margin non-GAAP | 1.1% | Three Months Ended March 31, 2026 | — |
| Net debt non-GAAP | 32.9M | March 31, 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
HBIO
this stock
Harvard Bioscience Inc
|
$34.05M | — | -3.8% | — | 1.3% |
|
ISRG
Intuitive Surgical Inc
|
$133.83B | -33.1% | +20.5% | 43.5 | 1.9% |
|
BDX
Becton Dickinson & Co
|
$52.30B | — | +8.2% | — | 3.7% |
|
MDLN
Medline Inc.
|
$45.04B | -18.4% | +11.5% | — | 2.6% |
|
ALC
Alcon Inc
|
$35.59B | -6.6% | +10.5% | — | 2.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
Raw-price comparisons begin at the captured split on Mar 16, 2026; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| HBIO | +12.3% | +24.7% | — | +22.6% | — |
| SPY | -1.4% | +3.6% | +11.6% | +2.5% | +12.3% |
| vs SPY | +13.7% | +21.0% | — | +20.1% | — |